Autoimmune disease

The FDA ( U.S. Food and Drug Administration ) has approved Cablivi ( Caplacizumab-yhdp ) in combination with plasma exchange...


The FDA ( U.S. Food and Drug Administration ) has approved Keytruda ( Pembrolizumab ), anti-PD-1 therapy, for the adjuvant...


The FDA ( U.S. Food and Drug Administration ) has approved Mayzent ( Siponimod ) tablets to treat adults with...



The European Commission has approved Keytruda ( Pembrolizumab ), an anti-PD-1 therapy, in combination with Pemetrexed ( Alimta ) and...


The European Commission ( EC ) has granted marketing authorization for Hulio, a biosimilar to Humira ( Adalimumab ), for...


The FDA ( U.S. Food and Drug Administration ) has approved Keytruda ( Pembrolizumab ), an anti-PD-1 therapy, in combination...


Patients with systemic lupus erythematosus ( SLE ) are at risk of irreversible damage across multiple organ systems because of...


Cancer immunotherapy with checkpoint inhibitors ( CPIs ) is associated with frequent immune-related adverse events ( irAEs ) and is...



The European Commission ( EC ) has granted marketing authorisation for Olumiant ( Baricitinib ) 4 mg and 2 mg...


The FDA ( U.S. Food and Drug Administration ) has approved Siliq ( Brodalumab ) to treat adults with moderate-to-severe...


The FDA ( U.S. Food and Drug Administration ) has approved Keytruda ( Pembrolizumab ), the anti-PD-1 ( programmed death...


Researchers have found early evidence that a common but harmless virus could be behind the celiac disease, by causing the...


The viruses hepatitis B and C may both be associated with an increased risk of Parkinson’s disease, according to a...


The U.S. Food and Drug Administration ( FDA ) has approved Keytruda ( Pembrolizumab ), an anti-PD-1 therapy, for the...


Multiple sclerosis is an autoimmune inflammatory neurological disease with complex aetiology where the causes are not completely known. The main...


Women represent nearly 8 out of every 10 people with autoimmune diseases. Although the hugely disproportionate statistics are well known,...


Immunotherapy in multiple myeloma is emerging as an effective modality in therapy of multiple myeloma with the approval of several...


Alopecia areata is an autoimmune disease characterized by hair loss mediated by CD8+ T cells. There are no reliably effective...